Sidley-Led Roche To Buy US Pharma Biz For $3.5B

By Dawood Fakhir ( September 18, 2025, 2:53 PM BST) -- Swiss pharmaceutical behemoth Roche Holding AG said Thursday that it has agreed to acquire U.S.-based clinical-stage biopharmaceutical company 89bio Inc. for up to approximately $3.5 billion to boost its portfolio in treatments for cardiovascular, renal and metabolic diseases....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login